Clinical Trial Update: Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the combination of radiotherapy with TTI-101 in patients with border-line resectable and locally advanced pancreatic duct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• TTI-101

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING